Related Experiment Videos
Diagnostic criteria for vascular dementia
1Department of Neurology, Academisch Ziekenhuis VU, Amsterdam, The Netherlands. p.scheltens@azvu.nl
Haemostasis
|July 27, 1999
Summary
Evaluating diagnostic criteria for vascular dementia (VaD), this review identifies the California and NINDS-AIREN criteria as most effective. Further research is needed to improve reliability, especially for differentiating mixed dementia types.
Area of Science:
- Neurology
- Neuroscience
- Geriatrics
Background:
- Vascular dementia (VaD) is a clinical syndrome of dementia linked to cerebrovascular disease.
- Accurate diagnosis is crucial but challenging due to heterogeneous causes and overlapping pathologies.
- Existing diagnostic criteria vary in their ability to define dementia, vascular disease, and their relationship.
Purpose of the Study:
- To review and evaluate current diagnostic criteria for vascular dementia.
- To assess the adequacy of these criteria in defining dementia, vascular pathology, and their causal link.
- To identify the most reliable criteria for clinical and research use.
Main Methods:
- Systematic review of established diagnostic criteria for vascular dementia.
- Analysis of criteria based on their inclusion of diagnostic elements for dementia, cerebrovascular disease, and the relationship between them.
- Evaluation of criteria's operational definitions and recommendations for neuroimaging (CT/MRI).
Main Results:
- The criteria from the State of California Alzheimer's Disease Diagnostic and Treatment Centers and NINDS-AIREN were found to be the most comprehensive.
- These selected criteria offer sufficient operational definitions for dementia in vascular disease patients.
- They also provide a framework for diagnosing cerebrovascular disease and establishing its link to dementia.
Conclusions:
- The California and NINDS-AIREN criteria are recommended for diagnosing vascular dementia.
- Further investigation is required for interpreting neuroimaging in mixed vascular and degenerative dementia.
- Improved diagnostic reliability for VaD is anticipated with the development of specific tests for differentiating degenerative diseases.